Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion type Assertion NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_head.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion description "[In a case-control study of Chinese women, we examined genotypes of the CYP11A1 pentanucleotide [(TAAAA)n] repeat (D15S520), CYP17A1 rs743572, and HSD17B1 rs605059 polymorphisms in relation to the risk of breast cancer and fibrocystic breast conditions, comparing 615 women with breast cancer and 467 women with fibrocystic breast conditions separately with 879 women without clinical breast disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion evidence source_evidence_literature NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion SIO_000772 18483327 NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion wasDerivedFrom befree-20150227 NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.
- NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_assertion wasGeneratedBy ECO_0000203 NP344477.RAvfrU2g7OBF6O6S2Yo8yH_SF3IOibNzA-9Ua-L5O-dL4130_provenance.